Mesoblast MESO
NASDAQ MESO
$14.28 -0.36 (-2.49%)
As of: Oct 1, 2026 · 3:47 PM EDT

Mesoblast (MESO) Long-Term Deferred Tax (2017 - 2021)

Updated

Mesoblast's Long-Term Deferred Tax was $80.21 million in the quarter ended Dec 31, 2021, up 0.1% from $80.12 million a year earlier and unchanged from the prior quarter.

Analysis

Mesoblast (MESO) Long-Term Deferred Tax (2017 - 2021) Analysis & Trends

As of Jun 30, 2021, Long-Term Deferred Tax at Mesoblast came in at $80.16 million, up 1.4% from the prior year.

  • Long-Term Deferred Tax has now increased for three consecutive years, with a four-year compound annual growth rate of 0.6% (years ended Jun 2017 to Jun 2021).
  • In earlier years, Long-Term Deferred Tax was $79.1 million in the year ended Jun 30, 2020 (+20.9%), $65.43 million in the year ended Jun 30, 2019 (+15.7%), $56.57 million in the year ended Jun 30, 2018 (-27.7%) and $78.23 million in the year ended Jun 30, 2017.
  • Quarterly Long-Term Deferred Tax has moved between $56.57 million (the quarter ended Jun 30, 2018) and $80.25 million (the quarter ended Sep 30, 2021) over five years.
  • Compared with a year earlier, Long-Term Deferred Tax has increased for nine straight quarters, with growth averaging 9.8% over the last eight quarters.
  • The best year-over-year quarter for Long-Term Deferred Tax over five years was the quarter ended Dec 31, 2019 (growth of 21.2%); the worst was the quarter ended Jun 30, 2018 (a decline of 27.7%).
  • Per Business Quant data, MESO's Long-Term Deferred Tax in the three quarters before the quarter ended Dec 31, 2021 was $80.25 million (quarter ended Sep 30, 2021), $80.16 million (quarter ended Jun 30, 2021) and $80.2 million (quarter ended Mar 31, 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Mesoblast 1.90 Bn 1.46 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 80.21 Mn
Sep 30, 2021 80.25 Mn
Jun 30, 2021 80.16 Mn
Mar 31, 2021 80.20 Mn
Dec 31, 2020 80.12 Mn
Sep 30, 2020 79.91 Mn
Jun 30, 2020 79.10 Mn
Mar 31, 2020 74.78 Mn
Dec 31, 2019 72.85 Mn
Sep 30, 2019 67.45 Mn
Jun 30, 2019 65.43 Mn
Mar 31, 2019 62.28 Mn
Dec 31, 2018 60.10 Mn
Jun 30, 2018 56.57 Mn
Jun 30, 2017 78.23 Mn
API Access

Mesoblast Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=MESO&period=max&api_key=YOUR_API_KEY